These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 20535093)

  • 1. Addition of severe combined immunodeficiency as a contraindication for administration of rotavirus vaccine.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2010 Jun; 59(22):687-8. PubMed ID: 20535093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Addition of history of intussusception as a contraindication for rotavirus vaccination.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2011 Oct; 60(41):1427. PubMed ID: 22012117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of rotavirus gastroenteritis among infants and children: recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Cortese MM; Parashar UD;
    MMWR Recomm Rep; 2009 Feb; 58(RR-2):1-25. PubMed ID: 19194371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rotavirus vaccine series completion and adherence to vaccination schedules among infants in managed care in the United States.
    Krishnarajah G; Davis EJ; Fan Y; Standaert BA; Buikema AR
    Vaccine; 2012 May; 30(24):3717-22. PubMed ID: 22214886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rotavirus vaccination coverage and adherence to the Advisory Committee on Immunization Practices (ACIP)-recommended vaccination schedule--United States, February 2006-May 2007.
    ;
    MMWR Morb Mortal Wkly Rep; 2008 Apr; 57(15):398-401. PubMed ID: 18418345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of rotavirus disease: guidelines for use of rotavirus vaccine.
    American Academy of Pediatrics Committee on Infectious Diseases
    Pediatrics; 2007 Jan; 119(1):171-82. PubMed ID: 17200286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccine discontinuation and switching following regulatory interventions in response to rotavirus vaccine contamination with porcine circovirus DNA fragments.
    Dore DD; Turnbull BR; Seeger JD
    Pharmacoepidemiol Drug Saf; 2012 Apr; 21(4):415-9. PubMed ID: 22290786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of rotavirus disease: updated guidelines for use of rotavirus vaccine.
    ;
    Pediatrics; 2009 May; 123(5):1412-20. PubMed ID: 19332437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severe combined immunodeficiency (SCID) and rotavirus vaccination: reports to the Vaccine Adverse Events Reporting System (VAERS).
    Bakare N; Menschik D; Tiernan R; Hua W; Martin D
    Vaccine; 2010 Sep; 28(40):6609-12. PubMed ID: 20674876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rotavirus vaccination coverage among infants aged 5 months - immunization information system sentinel sites, United States, June 2006-June 2009.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2010 May; 59(17):521-4. PubMed ID: 20448529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of pentavalent rotavirus vaccine in a large urban population in the United States.
    Boom JA; Tate JE; Sahni LC; Rench MA; Hull JJ; Gentsch JR; Patel MM; Baker CJ; Parashar UD
    Pediatrics; 2010 Feb; 125(2):e199-207. PubMed ID: 20083525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rotavirus vaccination compliance and completion in a Medicaid infant population.
    Krishnarajah G; Landsman-Blumberg P; Eynullayeva E
    Vaccine; 2015 Jan; 33(3):479-86. PubMed ID: 24962753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rotavirus live, oral, pentavalent vaccine.
    Tom-Revzon C
    Clin Ther; 2007 Dec; 29(12):2724-37. PubMed ID: 18201590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Notes from the field: rotavirus vaccine administration errors--United States, 2006-2013.
    Hibbs BF; Miller ER; Shimabukuro T;
    MMWR Morb Mortal Wkly Rep; 2014 Jan; 63(4):81. PubMed ID: 24476980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of the pentavalent rotavirus vaccine in preventing gastroenteritis in the United States.
    Wang FT; Mast TC; Glass RJ; Loughlin J; Seeger JD
    Pediatrics; 2010 Feb; 125(2):e208-13. PubMed ID: 20100757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety profile of rotavirus vaccines among individuals aged ≥8 months of age, United States, vaccine adverse event reporting system (VAERS), 2006-2019.
    Haber P; Tate J; Marquez PL; Moro PL; Parashar U
    Vaccine; 2021 Jan; 39(4):746-750. PubMed ID: 33267969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rotavirus vaccines: entering a new stage of deployment.
    Nakagomi O; Cunliffe NA
    Curr Opin Infect Dis; 2007 Oct; 20(5):501-7. PubMed ID: 17762784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rotavirus vaccines: targeting the developing world.
    Glass RI; Bresee JS; Turcios R; Fischer TK; Parashar UD; Steele AD
    J Infect Dis; 2005 Sep; 192 Suppl 1():S160-6. PubMed ID: 16088799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Postmarketing monitoring of intussusception after RotaTeq vaccination--United States, February 1, 2006-February 15, 2007.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2007 Mar; 56(10):218-22. PubMed ID: 17363890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccines: the pentavalent rotavirus vaccine: discovery to licensure and beyond.
    Heaton PM; Ciarlet M
    Clin Infect Dis; 2007 Dec; 45(12):1618-24. PubMed ID: 18198497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.